Indian Journal of Clinical Biochemistry

, Volume 20, Issue 1, pp 145–149 | Cite as

Oxidative stress in metabolic syndrome

  • Praveen Sharma
  • Sandhya Mishra
  • Peeyush Ajmera
  • Sandeep Mathur


As antioxidants play a protective role in the pathophysiology of diabetes and cardiovascular diseases, understanding the physiological status of antioxidant concentration among people at high risk for developing these conditions, such as Metabolic Syndrome, is of interest. In present study out of 187 first degree non-diabetic relatives and 192 non-diabetic spouses, 33.1% and 19.7% were found to have metabolic syndrome respectively. Subjects with metabolic syndrome (≥3 risk factors) had poor antioxidants status as reflected by significantly low levels of vitamin A, C & E and significantly increased (p<0.01) oxidative stress as compared to those without metabolic syndrome. At the same time serum insulin levels and insulin resistance were found to be significantly high (p<0.001) in metabolic syndrome. A strong positive correlation (r=0.946; p<0.001) between oxidative stress and insulin resistance was observed in metabolic syndrome. Low levels of antioxidants and increased oxidative stress with insulin resistance in metabolic syndrome suggests that besides therapeutic life style changes (TLC) as suggested in ATP III guidelines inclusion of antioxidant vitamins, fruits and vegetable could be beneficial to ward off the consequences of metabolic syndrome.

Key Words

Diabetes NIDDM CAD Metabolic syndrome Insulin Resistance Antioxidants Oxidative Stress 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Oberly, L.W. (1988) Free radicals and diabetes. Free Rad. Biol. Med. 5, 113–124.CrossRefGoogle Scholar
  2. 2.
    Halliwell, B. (1997) Antioxidants and human disease: a general introduction. Nutrition Reviews 55, S44–52.CrossRefGoogle Scholar
  3. 3.
    Diaz, M.N., Frei, B., Vita, J.A., Keaney, J.F. (1997) Antioxidants and Atherosclerotic Heart Disease. The New Eng. Jour. Med. 7, 408–16.CrossRefGoogle Scholar
  4. 4.
    Light, D.W., Carrier, M.J., Anggard, E.E. (2000) Antioxidants, diabetes and endothelial dysfunction. Cardiovasc. Res. 47, 457–464.CrossRefGoogle Scholar
  5. 5.
    Asplund, K. (2002) Antioxidant vitamins in the prevention of cardiovascular disease: a systematic review. J. Intern. Med. 251, 372–392.PubMedCrossRefGoogle Scholar
  6. 6.
    Isomaa, B., Almgren, P., Tuomi, T., Foren, B., Lahti, K., Nissen, M., Taskinen, M.R., Groop, L. (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 24, 683–689.PubMedCrossRefGoogle Scholar
  7. 7.
    Wilson, P.W., Kannel, W.B., Silbershatz, H., D’Agostino, R.B. (1999) Clustering of metabolic factors and coronary heart disease. Arch. Intern. Med. 159, 1104–1109.PubMedCrossRefGoogle Scholar
  8. 8.
    Lakka, H.M., Laaksonen, D.E., Lakka, T.A., Niskanen, L.K., Kumpusalo, E., Tuomilehto, J., Salonen, J.T. (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288, 2709–2716.PubMedCrossRefGoogle Scholar
  9. 9.
    Meigs, J.B. (2002) Epidemiology of the metabolic syndrome. Am J. Manag. Care. 8 (Suppl.), S283-S292.PubMedGoogle Scholar
  10. 10.
    National Institutes of Health (2001): Executive Summary. In Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (19), 2486–2497CrossRefGoogle Scholar
  11. 11.
    Elbein, S.C., Maxwell, T.M., Schumacher, M.C. (1991) Insulin and glucose levels and prevalence of glucose intolerance in pedigrees with multiple diabetic siblings. Diabetes 40, 1024–1032PubMedCrossRefGoogle Scholar
  12. 12.
    Mayer, E.J., Newman, B., Austin, M.A., Zhang, D., Quesenberry, C.P., Edwards, K., Selby, J.V. (1996) Genetic and environmental influences on insulin levels and the insulin resistance syndrome: an analysis of women twins. Am. J. Epidemiol. 143, 323–332.PubMedGoogle Scholar
  13. 13.
    Natelson, S., Thomas, C.C. (1971) In techniques of Clinical Chemistry 3rd ed., Publisher Springfield Illinois: 751–755Google Scholar
  14. 14.
    Natelson, S., Thomas, C.C. (1971) In techniques of Clinical Chemistry 3rd ed., Publisher Springfield Illinois: 162–165Google Scholar
  15. 15.
    Fabianek, J., DeFilippi, J., Rickards, T. and Herp, A. (1968). Micromethod for tocopherol determination in blood serum. Clin. Chem. 14, 456–62PubMedGoogle Scholar
  16. 16.
    Ohkawa, H., Ohishi, N. and Yagi, K. (1979) Assay for lipid peroxide in animal tissues by thiobarbituric acid reaction. Annal. Biochem. 95, 351–353.CrossRefGoogle Scholar
  17. 17.
    Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., Turner, R.L. (1985) Homeostasis model assessment; Insulin resistance and â cell function from fasting plasma glucose and insulin concentration in man, Diabetologia 28, 412–419.PubMedCrossRefGoogle Scholar
  18. 18.
    Bierman, E.L. (1992) George Lyman Duff Memorial Lecture: Atherogenesis in diabetes. Arterioscler. Thromb. 12, 647–656.PubMedGoogle Scholar
  19. 19.
    Keaney, J.F. and Loscalzo, J. (1999) Diabetes, Oxidative Stress, and Platelet Activation. Circulation 99, 189–191.PubMedGoogle Scholar
  20. 20.
    Esterbaur, H., Gebicki, J., Puhl, H., Jurgens, G. (1992) The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free. Rad. Biol. Med. 13, 341–391.CrossRefGoogle Scholar
  21. 21.
    Ford, S.E., Mokdad, A.H., Giles, W.H. and Brown, D.W. (2003) The Metabolic syndrome and antioxidant concentrations. Diabetes 52, 2346–2352.PubMedCrossRefGoogle Scholar

Copyright information

© Association of Clinical Biochemists of India 2005

Authors and Affiliations

  • Praveen Sharma
    • 1
  • Sandhya Mishra
    • 1
  • Peeyush Ajmera
    • 1
  • Sandeep Mathur
    • 2
  1. 1.Department of BiochemistryS.M.S. Medical CollegeJaipurIndia
  2. 2.Department of MedicineS.M.S. Medical CollegeJaipurIndia

Personalised recommendations